Organisation paid for research Program year 2025 Source: CMS Open Payments

Arrow Clinical Trials LLC

Neither a doctor nor a teaching hospital

Research payments

$413,544

11 payments

Through program year 2025, Arrow Clinical Trials LLC is reported as receiving $413,544 in research payments, across 11 payments.

By program year

2 rows

Year	Kind	Amount	Payments
2025	Research	$185,647	6
2024	Research	$227,897	5

Breakdown

Who paid Research payments · program years 2024–2025

Eli Lilly and Company $326,683 4 payments
Lexicon Pharmaceuticals, Inc. $86,860 7 payments

Studies the money was for Research payments · program years 2024–2025

A Phase 3, Randomized, Multicenter, Open-Label Study to Investigate the Efficacy and Safety of Retatrutide Once Weekly Compared With Semaglutide Once Weekly in Adult Participants With Type 2 Diabetes and Inadequate Glycemic Control With Metformin With Or Without Sglt2 Inhibitor (Transcend-T2d-2) $326,683 4 payments
Lx9211.1-204-Dpn $45,158 6 payments
Lx9211 $41,702 1 payment

What the money was spent on Research payments · program years 2024–2025

Patient care $49,335 3 payments

Only reported on some payments, and a payment can report more than one category, so these amounts overlap.

What you are looking at

A noncovered recipient is an organisation paid for research that is neither an individual clinician nor a teaching hospital — typically a contract research organisation, a foundation or a trial site network. They receive 81% of all reported research money, which is why they appear here at all.